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Introduction. Visceral leishmaniasis is the most severe clinical form of leishmaniasis and is
often fatal without proper treatment. Therefore, early and accurate diagnosis is important, but
often difficult in endemic areas.
Objective. The aim was to evaluate a direct agglutination test as a potential visceral
leishmaniasis diagnostic method in endemic areas of Venezuela
Materials and methods. The performance of the direct agglutination test, based on freeze-
dried Leishmania donovani antigen was evaluated under laboratory conditions using serum
samples of humans and dogs from several Venezuelan visceral leishmaniasis endemic areas:
Nueva Esparta (Margarita Island), Lara, Anzoátegui and Trujillo Status. The study included
confirmed visceral leishmaniasis patients (n=30), visceral leishmaniasis suspected subjects
(n=4), healthy controls (n=19) and patients with other confirmed diseases (n=20). In addition,
24 serum samples from dogs with confirmed visceral leishmaniasis and 18 healthy control
dogs were tested.
Results. All serum samples of visceral leishmaniasis patients, either active or recovered, were
positive. They showed anti-L. donovani titers above 1:1600. Three out of four suspected visceral
leishmaniasis cases were also positive, while serum samples from endemic controls and patients
with other diseases had titers lower than 1:800. A sensitivity of 100% was obtained for all
threshold levels under consideration and 100% specificity at the threshold titer of 1:800 (95%
confidence interval: 91-100%). A 93% sensitivity (95% confidence interval: 76-99%) was
observed in dog samples, with 100% specificity (95% confidence interval: 79-100%) at the
threshold titer of 1:200.
Conclusion. The direct agglutination test seems suitable for use in epidemiological studies
and for serological diagnosis of human visceral leishmaniasis and canine visceral leishmaniasis.
Key words: Leishmaniasis, visceral/diagnosis, agglutination tests, Leishmania donovani,
humans, dogs, Venezuela.
Evaluación de una prueba de aglutinación directa como método alternativo para el
diagnóstico de leishmaniasis visceral canina y humana en Venezuela
Introducción. La leishmaniasis visceral es la forma clínica más grave de la leishmaniasis. Ésta
puede ser fatal si no se administra el tratamiento adecuado. Por ello, el diagnostico temprano
es importante, pero a menudo difícil, en las áreas endémicas.
Objetivo. Evaluar el potencial de la prueba de aglutinación directa como un método para el
diagnóstico de leishmaniasis visceral en zonas endémicas de Venezuela.
Materiales y métodos. La efectividad de la prueba de aglutinación directa con el antígeno
congelación-descongelación de Leishmania donovani fue evaluada bajo condiciones de
laboratorio usando muestras de sueros de humanos y perros provenientes de diferentes regiones
endémicas de leishmaniasis visceral de Venezuela: Nueva Esparta (Isla de Margarita), Estados
Lara, Anzoátegui y Trujillo. Se incluyeron pacientes con diagnóstico confirmado de
leishmaniasis visceral (n=30), sospecha de leishmaniasis visceral (n=4), voluntarios sanos
(n=19) y pacientes con otras enfermedades (n=20). Además, se evaluaron 24 muestras de
suero de perros con leishmaniasis visceral y 18 controles.
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Resultados. Todas las muestras de los pacientes con leishmaniasis visceral activa o curada
fueron positivas. Mostraron títulos anti-L. donovani por encima de 1:1.600. Tres de cuatro
casos con sospecha de leishmaniasis visceral también resultaron positivos a la prueba, mientras
que los sueros controles y los de los pacientes con otras patologías dieron títulos por debajo
de 1:800. Se obtuvo una sensibilidad de 100% a todos los puntos de corte considerados y una
especificidad de 100% al punto de corte de 1:800 (intervalo de confianza de 95%, IC95%:
90,97%-100%). Las muestras de perros mostraron una sensibilidad de 92,59% (IC95%: 75,69%-
99,09%) y 100% de especificidad (IC95%: 79,42%-100%) al punto de corte de 1:200.
Conclusión. En general, nuestros resultados indican que el uso de la prueba de aglutinación
directa es apropiado para la realización de estudios epidemiológicos y para el diagnóstico
serológico de leishmaniasis visceral humana y canina en las áreas rurales de Venezuela.
Palabras clave: leishmaniasis visceral/diagnóstico, pruebas de aglutinación, Leishmania
donovani, humanos, perros, Venezuela
Visceral leishmaniasis is an infection caused by
parasites of the genus Leishmania, species L.
infantum (= L.chagasi) and L. donovani. These
parasites are transmitted by an insect vector per-
taining to the genera Lutzomyia or Phlebotomus
(Diptera: Psychodidae) from human to human
(anthroponotic transmission) or from an animal
reservoir to humans (zoonotic transmission) (1).
Visceral leishmaniasis is characterized by irregu-
lar bouts of fever, substantial weight loss, swell-
ing of the spleen and liver, and anemia. If left un-
treated, the fatality rate can be as high as 100%
(2). Therefore, early diagnosis is essential.
 Approximately 500,000 new cases of human vis-
ceral leishmaniasis occur annually, particularly in
East Africa, Brazil and India. In America, it is
widely distributed, from the northern provinces of
Argentina to the United States (3); more than 90%
of the human cases are reported from Brazil.
Visceral leishmaniasis is of increasing importance
in Venezuela. During the period 1995-2003, 378
cases of human visceral leishmaniasis were re-
ported in widely distributed foci. Seventy percent
of these cases occured in children between 0-10
years of age; the 1-2 year-old age group was the
most affected (4,5). One of the active areas of
visceral leishmaniasis in Venezuela is Margarita
Island. A recent study revealed an average infec-
tion rate of 21.6% in domestic dogs in eight en-
demic communities on the island (6).
The diagnosis of human visceral leishmaniasis is
difficult. The principal symptoms of it may be in-
distinguishable from those of other parasitic dis-
eases, such as malaria, schistosomiasis and syn-
dromes associated with liver and spleen enlarge-
ment (7). The clinical indicators of visceral leish-
maniasis can be confirmed by direct detection of
parasites. However, patient sampling is invasive,
parasite identification requires skilled microscopy,
and parasite isolation is expensive and difficult.
Moreover, diagnostic molecular techniques are not
readily applicable under field conditions. Because
of these limitations, a number of indirect immuno-
logical methods have been developed. These in-
clude the following: 1) fluorescent antibody test
(IFAT) (8,9); 2) ELISA method using whole killed
parasites (10,11) or defined leishmanial antigens
such as K39 (12); 3) immunochromatography (13),
and 4) direct agglutination test (DAT).
DAT is still the first line diagnostic tool in many
developing countries (14-16), as it is a simple test
with high sensitivity, specificity and reproducibil-
ity, easy to perform and does not require special-
ized equipment (17-19). However, the DAT has
not been validated in Venezuela. Therefore, the
performance of DAT was evaluated by using
freeze-dried L. donovani antigen in detecting anti-
Leishmania antibodies in sera from dogs and VL
patients. Serum samples from human patients
suffering from other diseases and apparently
healthy controls (human and canine samples) were
also included in order to determine the sensitivity
and specificity of the test.
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Materials and methods
Human serum samples
Serum samples, stored in the serum collection of
the “Instituto de Biomedicina, Universidad Central
de Venezuela” (Caracas, Venezuela), were used
to determine the sensitivity and specificity of the
DAT under laboratory conditions. The patient
samples were collected in four endemic areas:
Nueva Esparta (Margarita Island), Lara, Anzoátegui
and Trujillo States. The following groups of
samples were used: 1) sera from patients with
active clinical and parasitologically proven visceral
leishmaniasis (n=26), 2) sera from recovered
patients (n=4), 3) serum samples of patients
clinically suspected of visceral leishmaniasis
(n=4), 4) healthy blood donors from an endemic
area who had no history of visceral leishmaniasis
and no clinical symptoms of leishmaniasis (n=11),
5) non- endemic area control subjects (n=8), 6)
sera from patients with other confirmed diseases
(n=20). The latter group included 5 disease
categories: Chagas’ disease (n=4), leprosy (n=4),
dengue (n=4), giardiasis (n=4), and allergies (n=4).
Canine serum samples
Forty-two serum samples were collected in
endemic areas, from two different groups: 1) dogs
with clinical signs of VL. All these dogs were
parasitologically confirmed as VL, (CanVL, n=26),
and 2) healthy control dogs (n=16).
Direct agglutination test
The DAT was performed as described previously
(14,20,21). Briefly, serum samples were diluted
in physiological saline (0.9% NaCl) containing
0.8% β-mercaptoethanol. Two-fold dilutions of the
sera were made, starting at a dilution of 1:100
and going up to a maximum serum dilution of
1:102,400. Freeze-dried DAT antigen (stained L.
donovani promastigotes) produced by KIT Bio-
medical Research (The Netherlands) was recon-
stituted with physiological saline according to the
manufacturer’s instructions (21). Reconstituted (50
µL) antigen solution (concentration of 5 x 107 para-
sites per mL) was added to each well of the
microwell plate containing 50 µL of diluted serum.
The results were read visually after 18 hours of
incubation at ambient temperature. The end-point
titer was taken as the last well where agglutina-
tion was seen. This agglutination shows as blue
mats or enlarged blue dots in comparison to the
compact blue dots present in the negative control
wells.
Statistical analysis
The sensitivity and the specificity of the DAT were
calculated using the following formulas: Sensitiv-
ity = TPx100/(TP+FN) and Specificity = TNx100/
(TN+FP), where TN represents true negative, TP
true positive, FN false negative and FP false posi-
tive (22). Predictive values were calculated using
GraphPad INSTAT-3™ software, version 3.02
(GraphPad Software, San Diego, CA), by analy-
sis of 2x2 contingency tables. Sensitivity, speci-
ficity and predictive values of the DAT at 4 dilu-
tions (1:100, 1:200, 1:400 and 1:800) were esti-
mated with exact binomial 95% confidence inter-
vals (95% CI).
Ethical aspects
The study was approved by the research ethics
committee of the Biomedicine Institute.
Figure 1. Direct agglutination test (DAT) results for the
detection of human anti-Leishmania antibodies in various
patient and control groups. VL: visceral leishmaniasis,
endemic area controls, non-endemic area controls. Cross
bars indicate mean titer values for each group.
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Results
Human DAT titers
The distribution of DAT titers for human serum
samples is shown in figure 1. All serum samples
from visceral leishmaniasis patients had titers
>1:1,600. All serum samples tested from the re-
covered cases also showed DAT titers above
1:1,600. Similarly, 3 out of 4 samples from vis-
ceral leishmaniasis-suspected individuals showed
positive titers (titer>1:1,600), and one sample had
a titer of 1:400. Testing of serum samples from
endemic controls and patients with other diseases
resulted in DAT titers below 1:800.
Sensitivity and specificity
The DAT performance depends on the titer
threshold titer that is selected. Table 1 shows
sensitivity and specificity calculated with 95% CI
for values ranging from 1:100 to 1:800. Sensitivity
was 100% (no false results) for all titers
considered. The specificity gradually increased
across the dilution range to reach 100% specificity
at a titer of 1:800 (95% CI: 91.0%-100%). A
negative value of 100% was obtained at all
dilutions. In contrast, the positive predictive values
of 91.0% and 100% were obtained at titers of
1:400 (95% CI: 77.9%-97.41%) and 1:800 (95%
CI: 91.0%-100%), respectively.
Canine DAT titers, sensitivity and specificity
The DAT results for canine anti-Leishmania antibody
are summarized in figure 2. Twenty two out of 26
Table 1. Sensitivity, specificity, positive/negative predictive values, and likelihood ratios of the direct agglutination test (DAT)
for human anti-Leishmania antibodies at different cut-off titers.
Cut-off titer
1/100 1/200 1/400 1/800
Sensitivity (%)* 100 100 100 100
(90.97-100) (90.97-100) (90.97-100) (90.97-100)
Specificity (%) 58.97 71.79 89.74 100
(42.07-74.44) (55.09-85.02) (75.77-97.14) (90.97-100)
Positive predictive 70.91 78 90.70 100
value (%)* (57.11-82.39) (94.05-88.49) (77.88-97.41) (90.97-100)
Negative predictive 100 100 100 100
value (%)* (85.19-100) (87.66-100) (90.01-100) (90.97-100)
Likelihood ratio* 2.438 3.545 9.750 -
*Values in parentheses are 95% confidence intervals.
dogs with visceral leishmaniasis had titers above
1:400, while all canine control titers were 1:200 or
lower. However, the sensitivity was variable
(Table 2). A 96.2% sensitivity was obtained using
Figure 2. Direct agglutination test (DAT) results for the de-
tection of canine anti-Leishmania antibodies in various dog
groups. VL: visceral leishmaniasis. Cross bars indicate mean
titers for each group.
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Table 2. Sensitivity, specificity, positive/negative predictive values, and likelihood ratios of the direct agglutination test (DAT)
for canine anti-Leishmania antibodies at different cut-off titers.
Cut-off titer
1/100 1/200 1/400 1/800
Sensitivity (%)* 96.15 92.59 84.00 73.08
(80.38-99.90) (75.69-99.09) (63.92-95.46) (52.19-88.43)
Specificity (%)* 87.50 100 100 100
(61.65-98.45) (79.42-100) (79.42-100) (79.42-100)
Positive predictive 92.59 100 100 100
value (%)* (75.69-99.09) (86.29-100) (83.90-100) (82.37-100)
Negative Predictive 93.33 88.89 80 69.57
Value (%)* (68.06-99.83) (65.32-98.63) (56.33-94.27) (47.10-99.99)
Likelihood ratio 7.69 - - -
*Values in parentheses are 95% confidence limits.
a cut-off titer of 1:100 (95% CI: 80.4%-99.9%).
Interestingly, the specificity was optimal (100%:
95% CI: 79.4%-100%) at cut-off titers of 1:200,
1:400 and 1:800. Using a threshold titer of 1:200
or higher (1:400 and 1:800), the predictive positive
values were 100% (95% CI: 79.4%-100%). The
negative predictive value was 88.9% (95% CI:
65.3-98.6) at the threshold titer of 1:200.
Discussion
Visceral leishmaniasis is an important endemic
disease in Venezuela. Its incidence has increased
in recent years (4). Margarita Island is currently
the most active focus. Unfortunately, a high
percentage of affected people are children under
four years old (5). Although direct detection of the
parasite from patient samples is the optimum
method for confirmation of visceral leishmaniasis,
sampling is very uncomfortable for the patients,
especially for young children. In addition,
techniques to identify the parasite can be time
consuming, expensive and difficult; other indirect
methods, such as ELISA, require specialized
equipment. These considerations have encouraged
an evaluation of the performance of DAT for
visceral leishmaniasis serological diagnosis in
humans and canines in Venezuela.
The test showed very high sensitivity and
specificity for human sera, similar to previous
reports (20-23). Positive and negative predictive
values of 100% were obtained at a cut-off titer of
1:800. In addition, sera from recovered visceral
leishmaniasis patients were positive. This
conforms to the results of previous studies,
showing high antibody titers to Leishmania
donovani seven years after healing (14,25).
Moreover, similar observations have been reported
for recombinant K39-based ELISAs, (5,14)
However, these techniques do not discriminate
between active infection and past infection. An L.
infantum infection may be associated with dermal
lesions as well in susceptible individuals (children,
inmunocompromised patients and others);
sympatric transmission has been described (26-
28). In the current study, DAT was positive in a
patient with diffuse cutaneous leishmaniasis (data
not shown). Nevertheless, the clinical manifes-
tations of American cutaneous leishmaniasis have
been well characterized and significantly differ from
those observed for human visceral leishmaniasis
(29). Therefore, using similar conditions, DAT can
be used for serological diagnosis of human
visceral leishmaniasis in combination with the
clinical evaluation of the patients in endemic areas
where American cutaneous leishmaniasis and
visceral leishmaniasis coexist.
Dogs are important reservoirs in the infectious
cycle of L. infantum in the Mediterranean basin
and in Latin America, including Venezuela (6,30),
and probably plays an important role in visceral
leishmaniasis transmission. Hence, the presence
of seropositive dogs in human dwellings is
considered as a possible risk factor for L. infantum
infection (31-33). Consequently, early and accurate
diagnosis of canine leishmaniasis is needed to
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aid in the control of human and canine visceral
leishmaniasis and to reduce the transmission from
the reservoir to humans. As for human visceral
leishmaniasis, the diagnosis of canine visceral
leishmaniasis is a difficult task because the clinical
signs are variable, the histopathology is non-
specific and parasites are rarely seen (19).
The DAT was shown to constitute a good
alternative for the diagnosis of canine visceral
leishmaniasis, especially in that it can detect
infection at early stages (34). Using a dilution titer
of 1:200, the sensitivity and specificity of DAT
were 92.6% (two false negative results) and 100%,
respectively. These results were similar to those
found in other studies (35-37). Oskam et al. (37),
in the Old World (37), reported 100% sensitivity
and 98.8% specificity (titer threshold of 1:640).
Da Silva observed 100% sensitivity and 91%
specificity in Belo Horizonte (Minas Gerais, Brazil)
(35). In contrast, another study conducted in Para,
Brazil showed only 71.4% sensitivity (38). The
lower sensitivity of the latter study may have been
due to the use of a different antigen or to particular
characteristics of the parasites circulating in the
endemic area where it was carried out.
Under the current study conditions, the combina-
tion of sensitivity and specificity was optimal at
1:800 for humans and 1:200 for dogs. This is con-
sidered the recommended thresholds to be used
in future studies.
The direct agglutination test (DAT) is recom-
mended as a suitable tool for the sero-diagnosis
of human and canine visceral leishmaniasis in
Venezuelan endemic areas. It can provide valu-
able information to the public health authorities in
a rapid, timely interval.
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